|
|
|
|

*
Nutrition Matters, Inc., Port Townsend, WA 98368;
Stanford Center for Research in Disease Prevention, Palo Alto, CA 94304; and the
**
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, AL 35294
2To whom correspondence should be addressed. E-mail: markm{at}olympus.net
Research into the health effects of soyfoods and soybean constituents has increased at a phenomenal pace over the past decade. This research includes a wide range of areas, such as cancer, coronary heart disease, osteoporosis, cognitive function, menopausal symptoms and renal function. Importantly, there are an increasing number of clinical studies being conducted in this field, which was quite evident from the findings presented at the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, November 47, 2001, in San Diego, California. There is no doubt that progress in understanding the health effects of soy is being made, but much of the data are frustratingly inconsistent. For example, there were conflicting results presented at the symposium on the role of isoflavones in bone health. Similarly, presentations painted an unclear picture of the role of isoflavones in cholesterol reduction. The relatively short duration and small sample size of many of the human studies in this field likely contribute to the inconsistent results. Although there are some controversies regarding the safety of soy for certain subsets of the population, special sessions at the symposium on breast cancer and cognitive function did much to alleviate concerns that soy could have detrimental effects in these areas. Furthermore, published data and new research presented at this meeting suggest that the consumption of even 10 g (typical of Asian intake) of isoflavone-rich soy protein per day may be associated with health benefits. If this modest amount of soy protein were to be incorporated in the American diet, it would represent only
15% of total U. S. protein intake.
KEY WORDS: soy isoflavones cancer cholesterol intake
This article has been cited by other articles:
![]() |
A. A Thorp, P. R. Howe, T. A Mori, A. M Coates, J. D Buckley, J. Hodgson, J. Mansour, and B. J Meyer Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers Am. J. Clinical Nutrition, August 1, 2008; 88(2): 298 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jaceldo-Siegl, G. E Fraser, J. Chan, A. Franke, and J. Sabate Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, S. M. Edgerton, S. D. Kosanke, T. L. Mason, K. M. Alvarez, N. Liu, R. T. Chatterton, B. Liu, Q. Wang, A. Kim, et al. Hormonal and Dietary Modulation of Mammary Carcinogenesis in Mouse Mammary Tumor Virus-c-erbB-2 Transgenic Mice Cancer Res., May 15, 2003; 63(10): 2425 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Blum, S. N. Heaton, B. M. Bowman, M. Hegsted, and S. C. Miller Dietary Soy Protein Maintains Some Indices of Bone Mineral Density and Bone Formation in Aged Ovariectomized Rats J. Nutr., May 1, 2003; 133(5): 1244 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yonezawa, S. Nunomiya, M. Daigo, Y. Ogra, K. T. Suzuki, K. Enomoto, H. Nakagama, K. Yoshikawa, and M. Nagao Soy Protein Isolate Enhances Hepatic Copper Accumulation and Cell Damage in LEC Rats J. Nutr., May 1, 2003; 133(5): 1250 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barnes and M. Messina Introduction and Satellite Session at the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease J. Nutr., March 1, 2002; 132(3): 545S - 546. [Full Text] [PDF] |
||||